Drug Price Trends for NDC 69367-0397

Average Pharmacy Cost for 69367-0397

Drug Name	NDC	Price/Unit ($)	Unit	Date
LIDOCAINE-HC 3-0.5% CREAM	69367-0397-85	1.06205	GM	2025-03-19
LIDOCAINE-HC 3-0.5% CREAM	69367-0397-85	1.07998	GM	2025-02-19

Best Wholesale Price for NDC 69367-0397

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 69367-0397: Lidocaine Hydrochloride and Hydrocortisone Acetate

In the ever-evolving landscape of pharmaceuticals, understanding market trends and price projections for specific drugs is crucial for healthcare professionals, investors, and patients alike. Today, we'll dive deep into the market analysis and price projections for the drug identified by National Drug Code (NDC) 69367-0397, which corresponds to Lidocaine Hydrochloride and Hydrocortisone Acetate manufactured by Westminster Pharmaceuticals, LLC[5].

Understanding NDCs and Their Importance

Before we delve into the specifics of NDC 69367-0397, let's briefly explore what NDCs are and why they matter. The National Drug Code is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States[9]. It serves as a universal product identifier for drugs, playing a crucial role in various aspects of the pharmaceutical industry, from supply chain management to insurance claims processing.

"Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which is a universal product identifier for human drugs in the United States."[9]

Lidocaine Hydrochloride and Hydrocortisone Acetate: An Overview

Lidocaine Hydrochloride and Hydrocortisone Acetate is a combination medication used primarily for topical application. Lidocaine acts as a local anesthetic, while hydrocortisone is a corticosteroid that reduces inflammation. This combination is often used to treat various skin conditions, including minor burns, insect bites, and certain types of eczema.

Current Market Position

As of 2025, the pharmaceutical market is experiencing significant shifts, with several key trends shaping the industry landscape. Let's examine how these trends might impact the market position of Lidocaine Hydrochloride and Hydrocortisone Acetate.

Personalized Medicine and Its Impact

One of the most prominent trends in the pharmaceutical industry is the move towards personalized medicine. As Marwan Alsarraj, Associate Director of Marketing Programs at Bio-Rad Laboratories, notes:

"The potential of personalized medicine, and the shift towards treatments tailored to individual patients or genetic profiles, are not just promising, but are poised to revolutionize healthcare."[7]

While Lidocaine Hydrochloride and Hydrocortisone Acetate is not a personalized treatment per se, the growing focus on tailored therapies could potentially impact its market share. However, its broad applicability for various skin conditions may help maintain its relevance in the market.

Sustainability in Drug Manufacturing

Another significant trend is the increasing focus on sustainability in drug manufacturing. This shift towards more environmentally friendly practices could affect production costs and, consequently, pricing strategies for drugs like Lidocaine Hydrochloride and Hydrocortisone Acetate[7].

Price Projections and Influencing Factors

When it comes to projecting future prices for NDC 69367-0397, several factors come into play. Let's break them down:

Market Demand

The demand for Lidocaine Hydrochloride and Hydrocortisone Acetate is likely to remain stable or potentially increase, given its efficacy in managing various skin conditions. This stable demand could support moderate price increases[4].

Production Costs

Any fluctuations in production costs, such as changes in raw material prices or manufacturing overheads, could lead to price adjustments. The pharmaceutical industry's increasing focus on sustainability might also impact production costs[4].

Regulatory Environment

The regulatory landscape plays a significant role in drug pricing. Programs like Oregon's Drug Price Transparency Program can influence how manufacturers set and report prices[4]. As we move towards 2025 and beyond, any changes in healthcare policies or regulations could significantly impact drug pricing strategies.

Competition in the Market

The level of competition in the market for topical anesthetic and anti-inflammatory combinations will also influence pricing. If new, similar products enter the market, it could put downward pressure on prices.

Potential Price Increase Scenarios

Based on these factors, we can project two potential scenarios for price increases:

Moderate Increase Scenario

In this scenario, we might see a price increase of around 5-10% if market conditions remain relatively stable and there are no significant changes in production costs or the regulatory environment[4].

Higher Increase Scenario

If there's a surge in demand or significant increases in production costs, we could potentially see a more substantial price increase, possibly up to 15-20%[4]. However, it's important to note that such significant increases are less common for established generic drugs.

Impact on Healthcare Providers and Patients

The pricing of Lidocaine Hydrochloride and Hydrocortisone Acetate has direct implications for both healthcare providers and patients.

Cost-Benefit Analysis for Healthcare Providers

Healthcare providers must consider the cost-effectiveness of prescribing this medication. While it's effective for various skin conditions, any significant price increases could lead to a reassessment of its use in certain cases, especially if more affordable alternatives are available.

Patient Access and Affordability

For patients, the pricing of this medication directly affects their access to treatment. If prices increase substantially, it could limit access, particularly for uninsured or underinsured patients. This could potentially lead to negative health outcomes if patients are unable to afford necessary treatments[4].

Broader Pharmaceutical Market Trends

To put the projections for NDC 69367-0397 into context, let's look at some broader trends in the pharmaceutical market:

Growth in Prescription Drug Sales

According to Evaluate's 2024 World Preview Report, global prescription drug sales are expected to reach $1.7 trillion by 2030, marking a 7.7% growth rate[8]. This overall growth in the market could potentially support price increases for individual drugs.

Rise of Obesity Drugs

While not directly related to Lidocaine Hydrochloride and Hydrocortisone Acetate, the significant growth projected in the obesity drug market could impact overall pharmaceutical market dynamics. By 2030, five metabolic diseases drugs are expected to generate over $100 billion in combined sales[8].

Focus on Digital Therapeutics

The increasing focus on digital therapeutics and personalized medicine could reshape the pharmaceutical landscape[7]. While topical medications like Lidocaine Hydrochloride and Hydrocortisone Acetate may not be directly impacted by this trend, it could influence overall market dynamics and investment patterns in the industry.

Future Outlook and Considerations

As we look towards the future, several factors will be crucial in determining the market position and pricing of Lidocaine Hydrochloride and Hydrocortisone Acetate:

Potential for New Formulations

There may be opportunities for Westminster Pharmaceuticals, LLC to develop new formulations or delivery methods for this combination drug, which could impact its market position and pricing.

Shifts in Treatment Guidelines

Any changes in treatment guidelines for conditions typically treated with this medication could significantly impact demand and, consequently, pricing.

Technological Advancements in Manufacturing

Advancements in pharmaceutical manufacturing technologies could potentially reduce production costs, which might influence pricing strategies.

Global Market Expansion

The potential for expanding into new global markets could affect overall demand and pricing strategies for this medication.

Key Takeaways

• The pricing of Lidocaine Hydrochloride and Hydrocortisone Acetate (NDC 69367-0397) is influenced by factors including market demand, production costs, regulatory environment, and competition.
• Moderate price increases of 5-10% are possible, with potential for higher increases up to 15-20% in certain scenarios.
• The broader pharmaceutical market is projected to grow significantly, reaching $1.7 trillion in global prescription drug sales by 2030.
• Trends towards personalized medicine and digital therapeutics may indirectly impact the market for topical medications like Lidocaine Hydrochloride and Hydrocortisone Acetate.
• Patient access and affordability remain crucial considerations in pricing strategies.
• Future outlook depends on potential new formulations, changes in treatment guidelines, technological advancements, and global market expansion.

FAQs

1. What is the primary use of Lidocaine Hydrochloride and Hydrocortisone Acetate? This combination medication is primarily used topically to treat various skin conditions, including minor burns, insect bites, and certain types of eczema.

2. How might personalized medicine trends affect drugs like Lidocaine Hydrochloride and Hydrocortisone Acetate? While not directly impacted, the shift towards personalized treatments could potentially influence overall market dynamics and investment patterns in the pharmaceutical industry.

3. What factors could lead to higher price increases for this medication? Significant increases in production costs, surges in demand, or major changes in the regulatory environment could potentially lead to higher price increases.

4. How does the NDC system work? The National Drug Code is a unique, three-segment number assigned by the FDA to human drugs in the United States, serving as a universal product identifier.

5. What are some potential future developments for this medication? Future developments could include new formulations, improved delivery methods, or expansion into new global markets.

Sources cited: [4] https://www.drugpatentwatch.com/p/drug-price/ndc/31722-0356 [5] https://www.findacode.com/ndc/labelers/Westminster_Pharmaceuticals,_LLC--69367 [7] https://themedicinemaker.com/business-regulation/trends-and-therapeutic-areas-to-watch-in-2025 [8] https://www.evaluate.com/press_release/evaluate-releases-2030-forecasts-for-global-pharmaceutical-market/ [9] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information